Néovacs annonce la constitution de son comité clinique en vue de la préparation de la Phase III avec l'IFNalpha Kinoide en Lupus - 11 février à Paris
January 31, 2019 11:45 ET
|
NEOVACS
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE LA CONSTITUTION DE SON COMITÉ CLINIQUE EN VUE DE LA PREPARATION DE LA...
Neovacs announces its clinical advisory board meeting to design the Phase III Study for IFNalpha Kinoide in lupus - Paris February 11th
January 31, 2019 11:45 ET
|
NEOVACS
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES ITS CLINICAL ADVISORY BOARD MEETING TO DESIGN THE PHASE III STUDY FOR IFN-K IN LUPUS MEETING TO BE HELD IN PARIS,...
Néovacs présentera les résultats complets de l'étude clinique de Phase IIb avec l'IFNalpha Kinoïde au 13th International Lupus Congress
January 24, 2019 11:45 ET
|
NEOVACS
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTERA LES RÉSULTATS COMPLETS DE L’ÉTUDE CLINIQUE DE PHASE IIb AVEC l’IFNα Kinoïde AU 13TH INTERNATIONAL...
Neovacs to present full results from the Phase IIb IFNalpha Kinoid clinical study at the 13th International Lupus Congress
January 24, 2019 11:45 ET
|
NEOVACS
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT FULL RESULTS FROM THE PHASE IIb IFNalpha KINOID CLINICAL STUDY AT THE 13TH INTERNATIONAL LUPUS CONGRESS (LUPUS 2019)5 - 9...
Minor League Baseball and Lupus Foundation of America Partner to Raise Awareness of Lupus Among U.S. Hispanic/Latinx Fans
December 11, 2018 14:00 ET
|
Minor League Baseball
LAS VEGAS, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Minor League Baseball™ (MiLB™) today announced a partnership with the Lupus Foundation of America (LFA) to become an Official Partner of MiLB Copa de la...
Progentec Diagnostics, Inc. Raises Funds to Support Advances in Lupus Detection and Management
October 31, 2018 09:42 ET
|
Progentec Diagnostics, Inc.
New funding brings lupus-detection tools closer to commercialization Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Oct. ...
UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
October 23, 2018 01:00 ET
|
Biogen Inc.; UCB
BRUSSELS, Belgium and CAMBRIDGE, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Today UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) announced top-line results from a Phase 2b study...
Exagen Announces Launch of Novel Biomarker PC4d Associated with Thrombosis in Lupus
October 12, 2018 10:01 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, announced today that it will be updating the popular AVISE® SLE Monitor...
Terry Bradshaw Encourages Patients to “Take the Pledge to Live Well” in New PSA about Rheumatic Disease
August 23, 2018 17:00 ET
|
American College of Rheumatology
Atlanta, Aug. 23, 2018 (GLOBE NEWSWIRE) -- This September, Sports Broadcaster Terry Bradshaw is teaming up once again with the American College of Rheumatology (ACR) to share important information...
Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test
August 20, 2018 11:20 ET
|
Exagen Diagnostics, Inc.
Albuquerque and San Diego, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test, see full...